Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Rectal Cancer

6 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Other

VICCGI0721

01/09/2007

Vanderbilt Hereditary Colorectal Cancer Registry

Treatment

VICCGI14109

07/01/2015

An Open-Label Expanded Access Study of TAS-102 in Patients with Metastatic Colorectal Cancer Refractory to or Failing Standard Chemotherapy

Treatment

VICCGI14104

06/08/2015

Randomized, Blinded, Multicenter, Phase 2 Study Comparing Veliparib Plus FOLFIRI ? Bevacizumab Versus Placebo Plus FOLFIRI ? Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Treatment

VICCGI13102

12/09/2014

A Phase II Study of Panitumumab in Combination with FOLFIRI after Progression on FOLFIRI plus Bevacizumab in KRAS and NRAS Wild Type Metastatic Colorectal Cancer

Treatment

VICCGI13101

06/24/2014

Randomized, Double-Blind, Phase II Trial of Vitamin D Supplementation in Participants with Previously Untreated Metastatic Colorectal Cancer

Treatment

VICCMD1188

06/08/2012

An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers